Oxford University Hospitals NHS Trust

What Oxford University Hospitals NHS Trust does

Oxford University Hospitals NHS Foundation Trust (OUH) is one of the largest NHS teaching trusts in the United Kingdom, operating four acute hospital sites in Oxfordshire — John Radcliffe Hospital, Churchill Hospital, Nuffield Orthopaedic Centre, and Horton General Hospital — supplemented by satellite radiotherapy centres in Swindon and Milton Keynes. The trust serves an approximate catchment population of 2.3 million for specialist services spanning Oxfordshire, Berkshire, Buckinghamshire, and Wiltshire, and is a designated principal treatment centre for children's cancer (one of 20 in the UK) and Thames Valley Regional Centre for gynaecological cancer.

OUH's core clinical portfolio covers emergency and acute medicine, specialist surgical services, cancer diagnosis and treatment, diagnostic pathology, maternity, and paediatrics. The trust runs advanced radiotherapy infrastructure including MR Linac, Varian Halcyon and iX2100 linear accelerators, and CT planning scanners, and operates specialist units such as Kamran's Ward (children's haematology/oncology), the Jane Ashley Women's Centre, the Metabolic Bone Unit, and the TYA Cancer Service for patients aged 16-24. Digital infrastructure includes Cancer 360, a cancer pathway management platform built on Palantir's Federated Data Platform that feeds a Cancer Operations Centre with aggregated performance data. The Cellular Pathology service holds UKAS accreditation and the Radiotherapy Department is ISO 9001:2015 certified.

OUH's revenue model is anchored in NHS public funding: NHS England specialised commissioning and Oxfordshire Integrated Care Board contracts provide the majority of income through block grants, with services delivered free at point of use under the NHS Constitution. A secondary revenue stream derives from private patient services (self-pay and insured) at OUH private healthcare facilities. The trust holds no venture capital or private equity exposure, operating as an independent public benefit corporation with a council of governors, and is formally affiliated with the University of Oxford for teaching, clinical training, and research, including designation as an NIHR Biomedical Research Centre. Research funding partnerships with Cancer Research UK, the Medical Research Council, and the CRUK/MRC Oxford Institute for Radiation Oncology supplement core NHS funding and underpin the trust's translational medicine positioning.

Name

Oxford University Hospitals NHS Trust

Legal name

Oxford University Hospitals NHS Foundation Trust

Website

https://ouh.nhs.uk

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Oxford University Hospitals NHS Foundation Trust is one of the UK's largest NHS teaching trusts, operating four Oxfordshire hospital sites and satellite radiotherapy centres serving a 2.3 million catchment population across the Thames Valley with acute, specialist, cancer, and paediatric services.

Ownership category

akta.pro rank

Product category

Acute Hospital Services (NHS Teaching Trust)

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Hospitals (622)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)

akta.pro primary industry

Safety-Net & Public Hospitals (HLAFAAAD)

akta.pro secondary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Acute hospital services
• NHS teaching hospital
• Cancer treatment services
• Specialist tertiary care
• Radiotherapy services

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. NHS Public Healthcare Funding: Core revenue from NHS England and NHS Transformation Directorate block grant allocations for providing acute hospital services to the Oxfordshire population and specialist services to wider catchment areas.
2. Private Healthcare Services: Revenue from fee-paying private patients who choose to receive treatment at OUH private healthcare facilities, including private rooms and consultant services.

Pricing tiers

Distribution channels4 records

Marketing channels4 records

Core offering

Oxford University Hospitals NHS Foundation Trust delivers publicly funded acute hospital and specialist tertiary care across four hospital sites in Oxfordshire (John Radcliffe, Churchill, Nuffield Orthopaedic Centre, Horton General), plus satellite radiotherapy centres in Swindon and Milton Keynes. The Trust provides emergency medicine, elective surgery, cancer diagnosis and treatment, children's services, maternity care, orthopaedics, pathology and microbiology diagnostics, and clinical research enabled through its University of Oxford partnership.

Product overview

Oxford University Hospitals NHS Foundation Trust operates as a major NHS acute hospital trust with four main sites: John Radcliffe Hospital, Churchill Hospital, Nuffield Orthopaedic Centre, and Horton General Hospital. The Trust provides a comprehensive portfolio of clinical services spanning emergency and acute medicine, specialist surgical services, cancer care, diagnostics, and community services. Key service lines include the Children's Hospital (with dedicated Haematology and Oncology via Kamran's Ward), Cellular Pathology and Microbiology diagnostic laboratories, the Teenage and Young Adult Cancer Service (TYA), and comprehensive radiotherapy services across Oxford, Swindon, and Milton Keynes. The Trust employs digital health solutions including Cancer 360 for pathway management and operates specialist centres including the Jane Ashley Women's Centre for breast and gynaecological cancer, and the Metabolic Bone Unit for osteoporosis care. The portfolio includes NHS clinical services organized by disease type and body system, supported by research partnerships with the University of Oxford and charitable partners including Oxford Hospitals Charity and Teenage Cancer Trust.

Differentiator

Problem solved

Functional benefit

Brands

• Oxford Cancer Centre: Specialist cancer treatment centre at the Churchill Hospital site.
• Children's Hospital
• Oxford Kidney Unit
• TYA Cancer Services
• Kamran's Ward
• Oxford Radiotherapy Centre
• Maggie's Oxford
• Oxford Hospitals Charity

Products and services

• John Radcliffe Hospital Major acute hospital site in Oxford providing emergency departments, specialist services including the Children's Hospital, Women's Centre, and comprehensive clinical departments across tertiary services.
• Churchill Hospital Specialist hospital site housing the Oxford Cancer Centre, Cancer and Haematology Centre, radiotherapy services, and Teenage and Young Adult (TYA) Cancer Services.
• Nuffield Orthopaedic Centre Specialist orthopaedic centre providing bone and joint services, osteoporosis care, metabolic bone services, and limb reconstruction.
• Horton General Hospital District general hospital providing acute services, emergency medicine, and local hospital services for the Banbury and north Oxfordshire area.
• Children's Hospital at John Radcliffe Dedicated children's hospital providing paediatric haematology and oncology, acute paediatrics, children's therapies, and age-appropriate care for patients from birth to 18 years.
• Cellular Pathology Services UKAS-accredited diagnostic pathology service comprising Histopathology and Cytopathology laboratories offering A-Z diagnostic testing including histology specimens, cytology, fine needle aspirates, and electron microscopy.
• Microbiology Department Diagnostic microbiology service at John Radcliffe Hospital providing clinical microbiology testing, antimicrobial guidance, and diagnostic stewardship.
• Cancer 360 Data-driven cancer care pathway management product enabling care teams to coordinate patient scheduling, identify actions for treatment optimisation, and provide aggregated performance data for service improvement through the Cancer Operations Centre, built on Palantir Federated Data Platform technology.
• Teenage and Young Adult (TYA) Cancer Services Age-appropriate specialist cancer care service for patients aged 16-24, providing dedicated facilities, peer support, psychological services, fertility preservation guidance, and coordinated care across the Thames Valley region.
• Oxford Cancer Centre Radiotherapy Comprehensive radiotherapy centre equipped with Varian linear accelerators (Halcyon and iX2100), MR Linac, CT planning scanners, and brachytherapy services for cancer treatment across Oxford, Swindon, and Milton Keynes sites.
• Metabolic Bone Unit and Oxfordshire Osteoporosis Service Specialist osteoporosis and metabolic bone disease service at Nuffield Orthopaedic Centre providing DEXA scanning, fracture prevention clinics, and countywide hub for osteoporosis care.
• Children's Haematology and Oncology (Kamran's Ward) One of 20 Principal Treatment Centres in the UK for children's cancer, providing diagnosis and treatment of leukaemia, solid tumours, brain tumours, plus care for non-malignant blood conditions including sickle cell disease and haemophilia.
• OUH Macmillan Late Effects Service Specialist service for adults experiencing long-term side effects following radiotherapy treatment, offering specialist advice and management through face-to-face clinics and telephone/video consultations.
• Jane Ashley Women's Centre Specialist centre for breast and gynaecological cancer care at Churchill Hospital, serving as the Thames Valley Regional Centre for gynaecological cancer.
• Radiotherapy at OUH Swindon Satellite radiotherapy centre at Great Western Hospital providing treatment delivery with Truebeam linear accelerators and CT planning, serving patients in Swindon and surrounding areas.
• Radiotherapy at OUH Milton Keynes Satellite radiotherapy centre at Milton Keynes University Hospital offering radiotherapy treatment with surface guidance technology for patient positioning.
• Private Healthcare Services Fee-paying private patient services including private rooms and consultant services for self-pay and insured patients at OUH facilities.

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core and major.

• Palantir Technologies UK LTDcoreTechnology or Integration · 10 October 2025Palantir provides the data platform technology underlying the Cancer 360 product, which supports cancer care pathway management. Palantir acts as a processor acting on behalf of the Trust under data protection law.
• Future Fertility TrustcoreStrategic or Co-development PartnerCharitable trust supporting fertility preservation services for young cancer patients undergoing chemotherapy or radiotherapy, providing tissue cryopreservation and reimplantation services.
• Oxford Hospitals CharitycoreStrategic or Co-development PartnerOfficial hospital charity providing fundraising support for patient care improvements, equipment, research, and staff welfare across OUH sites.
• Teenage Cancer TrustcoreStrategic or Co-development PartnerFunding for Teenage Cancer Trust Lead Nurse position and youth support coordinator, providing age-appropriate cancer care facilities and support for young people aged 16-24.
• Young Lives vs Cancer (formerly CLIC Sargent)coreStrategic or Co-development PartnerSocial work support charity providing financial and emotional support to young cancer patients and their families, including welfare advice and help with accessing funding.
• University of OxfordcoreStrategic or Co-development PartnerAcademic partner providing research collaboration, clinical trial access, and integration with University of Oxford's biomedical research programmes including Comprehensive Biomedical Research Centre designation.
• Cancer Research UKcoreStrategic or Co-development PartnerMajor research funder with major investments on the Churchill site including Cancer Research Institute and Radiobiology Research Institute.
• Medical Research Council (MRC)coreStrategic or Co-development PartnerGovernment research funding body co-investing in radiotherapy research through CRUK/MRC Oxford Institute for Radiation Oncology.
• NIHR Oxford Biomedical Research CentrecoreStrategic or Co-development PartnerNational Institute for Health and Care Research designated research centre enabling fast-tracking of research into clinical care, with cancer as a main research programme.
• Ashley Charitable TrustmajorStrategic or Co-development PartnerMajor donor family (Ashley family) whose generosity founded the Jane Ashley Unit in 1996, now expanded to the Women's Centre for breast and gynaecological cancer care.
• Macmillan Cancer SupportcoreStrategic or Co-development PartnerFunding for Macmillan Clinical Psychologist position and OUH Macmillan Late Effects Service supporting cancer survivors with long-term treatment effects.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/OUHospitals
• YouTubeyoutube.com/ouhnhs
• Facebookfacebook.com/OUHospitals
• LinkedInlinkedin.com/company/6237274
• Instagraminstagram.com/ouhospitals

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford University Hospitals NHS Trust